Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
19 Sep 2024 |
TM01 |
Termination of appointment of William John Robert Fleming as a director on 18 September 2024
|
|
|
02 Jul 2024 |
AA01 |
Current accounting period extended from 30 June 2024 to 31 December 2024
|
|
|
28 Jun 2024 |
CS01 |
Confirmation statement made on 24 June 2024 with no updates
|
|
|
24 May 2024 |
AD03 |
Register(s) moved to registered inspection location 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT
|
|
|
24 May 2024 |
AD02 |
Register inspection address has been changed to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT
|
|
|
26 Sep 2023 |
AA |
Total exemption full accounts made up to 30 June 2023
|
|
|
27 Jun 2023 |
CS01 |
Confirmation statement made on 24 June 2023 with updates
|
|
|
14 Mar 2023 |
MA |
Memorandum and Articles of Association
|
|
|
14 Mar 2023 |
RESOLUTIONS |
Resolutions
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
10 Mar 2023 |
TM01 |
Termination of appointment of David James Kerr as a director on 21 February 2023
|
|
|
09 Mar 2023 |
TM01 |
Termination of appointment of James Julian Noble as a director on 21 February 2023
|
|
|
09 Mar 2023 |
TM01 |
Termination of appointment of Richard Kirby Taylor as a director on 21 February 2023
|
|
|
30 Jan 2023 |
PSC05 |
Change of details for Celleron Therapeutics Holdings Limited as a person with significant control on 26 January 2023
|
|
|
24 Jan 2023 |
TM02 |
Termination of appointment of Douglas Fraser Mcdonald as a secretary on 22 December 2022
|
|
|
17 Jan 2023 |
SH08 |
Change of share class name or designation
|
|
|
16 Jan 2023 |
PSC02 |
Notification of Celleron Therapeutics Holdings Limited as a person with significant control on 22 December 2022
|
|
|
16 Jan 2023 |
PSC07 |
Cessation of Nicholas Barrie La Thangue as a person with significant control on 22 December 2022
|
|
|
16 Jan 2023 |
TM01 |
Termination of appointment of Sangwoo Lee as a director on 22 December 2022
|
|
|
28 Sep 2022 |
AA |
Total exemption full accounts made up to 30 June 2022
|
|
|
15 Sep 2022 |
RESOLUTIONS |
Resolutions
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES10 ‐
Resolution of allotment of securities
|
|
|
18 Jul 2022 |
CS01 |
Confirmation statement made on 24 June 2022 with updates
|
|
|
01 Jul 2022 |
PSC04 |
Change of details for Prof Nicholas Barrie La Thangue as a person with significant control on 24 June 2022
|
|
|
30 Jun 2022 |
CH01 |
Director's details changed for Mr James Noble on 24 June 2022
|
|
|
30 Jun 2022 |
CH01 |
Director's details changed for Prof Nicholas Barrie La Thangue on 24 June 2022
|
|
|
30 Jun 2022 |
CH01 |
Director's details changed for Prof Nicholas Barrie La Thangue on 30 June 2022
|
|